MetaVia, Inc. (MTVA)
1.29
+0.06
(+4.88%)
USD |
NASDAQ |
Oct 20, 16:00
1.27
-0.02
(-1.55%)
After-Hours: 05:46
MetaVia Price to Book Value : 1.243 for Oct. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 20, 2026 | 1.243 |
| October 19, 2026 | 1.186 |
| October 16, 2026 | 1.214 |
| October 15, 2026 | 1.320 |
| October 14, 2026 | 1.311 |
| October 13, 2026 | 1.378 |
| October 12, 2026 | 1.398 |
| October 09, 2026 | 1.359 |
| October 08, 2026 | 1.292 |
| October 07, 2026 | 1.407 |
| October 06, 2026 | 1.427 |
| October 05, 2026 | 1.484 |
| October 02, 2026 | 1.484 |
| October 01, 2026 | 1.484 |
| September 30, 2026 | 1.513 |
| September 29, 2026 | 1.600 |
| September 28, 2026 | 1.610 |
| September 25, 2026 | 1.600 |
| September 24, 2026 | 1.571 |
| September 23, 2026 | 1.571 |
| September 22, 2026 | 1.619 |
| September 21, 2026 | 1.610 |
| September 18, 2026 | 1.668 |
| September 17, 2026 | 1.533 |
| September 16, 2026 | 1.484 |
| Date | Value |
|---|---|
| September 15, 2026 | 1.523 |
| September 14, 2026 | 1.562 |
| September 11, 2026 | 1.600 |
| September 10, 2026 | 1.687 |
| September 09, 2026 | 1.677 |
| September 08, 2026 | 1.639 |
| September 04, 2026 | 1.687 |
| September 03, 2026 | 1.774 |
| September 02, 2026 | 1.754 |
| September 01, 2026 | 1.658 |
| August 31, 2026 | 1.658 |
| August 28, 2026 | 1.639 |
| August 27, 2026 | 1.600 |
| August 26, 2026 | 1.619 |
| August 25, 2026 | 1.581 |
| August 24, 2026 | 1.475 |
| August 21, 2026 | 1.407 |
| August 20, 2026 | 1.388 |
| August 19, 2026 | 1.417 |
| August 18, 2026 | 1.436 |
| August 17, 2026 | 1.427 |
| August 14, 2026 | 1.436 |
| August 13, 2026 | 1.407 |
| August 12, 2026 | 1.417 |
| August 11, 2026 | 1.369 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.693 |
| Alnylam Pharmaceuticals, Inc. | 22.79 |
| Anika Therapeutics, Inc. | 1.993 |
| Savara, Inc. | 6.806 |
| Vericel Corp. | 5.612 |
Price to Book Value Related Metrics
| Price | 1.29 |
| Earnings Yield | -313.2% |
| Market Cap | 8.483M |